Panagora Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$916K Hold
4,080
﹤0.01% 728
2025
Q4
$983K Sell
4,080
-16
-0.4% -$4.09K ﹤0.01% 723
2025
Q3
$1.12M Sell
4,096
-2,565
-39% -$701K ﹤0.01% 634
2025
Q2
$1.72M Buy
6,661
+63
+1% +$15K 0.01% 510
2025
Q1
$1.48M Buy
6,598
+1,154
+21% +$269K 0.01% 585
2024
Q4
$1.24M Sell
5,444
-1,682
-24% -$405K 0.01% 616
2024
Q3
$1.74M Sell
7,126
-1
-0% -$223 0.01% 563
2024
Q2
$1.36M Sell
7,127
-4,386
-38% -$890K 0.01% 620
2024
Q1
$2.28M Hold
11,513
0.01% 536
2023
Q4
$1.98M Sell
11,513
-880
-7% -$135K 0.01% 567
2023
Q3
$1.83M Buy
12,393
+2,812
+29% +$508K 0.01% 551
2023
Q2
$2.09M Hold
9,581
0.01% 522
2023
Q1
$2.1M Sell
9,581
-2,503
-21% -$543K 0.01% 560
2022
Q4
$2.52M Sell
12,084
-1,790
-13% -$393K 0.02% 561
2022
Q3
$3.03M Hold
13,874
0.02% 492
2022
Q2
$2.91M Hold
13,874
0.02% 526
2022
Q1
$3.37M Sell
13,874
-20,960
-60% -$5.07M 0.02% 518
2021
Q4
$9.07M Sell
34,834
-122,552
-78% -$31.8M 0.05% 307
2021
Q3
$41.5M Sell
157,386
-4,083
-3% -$1.12M 0.22% 102
2021
Q2
$39.8M Buy
161,469
+126,171
+357% +$26.5M 0.21% 110
2021
Q1
$6.85M Buy
35,298
+19,430
+122% +$3.9M 0.04% 391
2020
Q4
$3.37M Sell
15,868
-2,535
-14% -$505K 0.02% 535
2020
Q3
$3.15M Buy
18,403
+952
+5% +$176K 0.02% 503
2020
Q2
$3.35M Sell
17,451
-8,242
-32% -$1.35M 0.02% 513
2020
Q1
$3.78M Buy
25,693
+15,124
+143% +$2.41M 0.03% 415
2019
Q4
$1.64M Sell
10,569
-311
-3% -$44.8K 0.01% 869
2019
Q3
$1.47M Sell
10,880
-150
-1% -$19.7K 0.01% 873
2019
Q2
$1.35M Buy
11,030
+39
+0.4% +$4.32K 0.01% 1008
2019
Q1
$1.14M Sell
10,991
-257,800
-96% -$26.6M 0.01% 1061
2018
Q4
$30.6M Buy
268,791
+5,264
+2% +$564K 0.14% 157
2018
Q3
$30.4M Buy
263,527
+50,354
+24% +$5.52M 0.11% 181
2018
Q2
$22.1M Buy
213,173
+202,239
+1,850% +$20.5M 0.09% 221
2018
Q1
$1.08M Sell
10,934
-182
-2% -$17.2K ﹤0.01% 1129
2017
Q4
$941K Buy
11,116
+2,396
+27% +$198K ﹤0.01% 1158
2017
Q3
$671K Buy
8,720
+200
+2% +$15.3K ﹤0.01% 1263
2017
Q2
$663K Sell
8,520
-141,423
-94% -$10.1M ﹤0.01% 1265
2017
Q1
$10.8M Sell
149,943
-812,627
-84% -$56.2M 0.04% 400
2016
Q4
$59.7M Sell
962,570
-235,123
-20% -$14.4M 0.27% 90
2016
Q3
$77.6M Buy
1,197,693
+121,020
+11% +$8.06M 0.37% 60
2016
Q2
$68.1M Buy
1,076,673
+417,136
+63% +$24.6M 0.34% 64
2016
Q1
$38.1M Buy
659,537
+618,968
+1,526% +$35M 0.19% 118
2015
Q4
$2.18M Buy
40,569
+11,055
+37% +$623K 0.01% 794
2015
Q3
$1.5M Buy
29,514
+21,162
+253% +$1.14M 0.01% 860
2015
Q2
$471K Buy
8,352
+75
+0.9% +$4.73K ﹤0.01% 1353
2015
Q1
$594K Hold
8,277
﹤0.01% 1256
2014
Q4
$464K Hold
8,277
﹤0.01% 1311
2014
Q3
$408K Hold
8,277
﹤0.01% 1379
2014
Q2
$419K Hold
8,277
﹤0.01% 1443
2014
Q1
$370K Hold
8,277
﹤0.01% 1535
2013
Q4
$390K Sell
8,277
-228,880
-97% -$11.6M ﹤0.01% 1467
2013
Q3
$12.5M Sell
237,157
-24,858
-9% -$1.21M 0.06% 299
2013
Q2
$11.8M Buy
+262,015
New +$12.4M 0.06% 268

Other funds holding RMD

Panagora Asset Management's RMD Position: Q1 2026 in Review

Panagora Asset Management held its ResMed (RMD) position steady in Q1 2026 at 4,080 shares worth $916K. The position accounts for ﹤0.01% of the portfolio, ranked #728.

Panagora Asset Management first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $77.6M in Q3 2016. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Panagora Asset Management held 4,080 shares of ResMed worth $916K as of Q1 2026.
  • Panagora Asset Management left its ResMed share count unchanged in Q1 2026.
  • ResMed made up ﹤0.01% of Panagora Asset Management's portfolio in Q1 2026, its #728 holding.
  • Panagora Asset Management first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Panagora Asset Management's ResMed position peaked at $77.6M in Q3 2016.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.